Sulfonylurea-induced hypoglycaemia — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Stop the sulfonylurea, give octreotide and continue monitored glucose support because recurrent insulin release may persist
The best answer is “Stop the sulfonylurea, give octreotide and continue monitored glucose support because recurrent insulin release may persist”. Sulfonylurea-associated hypoglycaemia can recur after dextrose stimulates further insulin release, particularly with kidney impairment and poor intake. Octreotide suppresses pancreatic insulin secretion while glucose and electrolytes are monitored. A single normal reading is not safe discharge evidence; the culprit medicine should not be restarted before a full regimen review.
Reference: Australian Diabetes Society: Australian type 2 diabetes glycaemic management algorithm: https://www.diabetessociety.com.au/guideline/australian-t2d-glycaemic-management-algorithm-june-2024/